Page 90
Gastro 2016
August 11-12, 2016
Volume 6, Issue 4(Suppl)
J Gastrointest Dig Syst 2016
ISSN:2161-069X JGDS, an open access journal
conferenceseries
.com
August 11-12, 2016 Birmingham, UK
6
th
Global Gastroenterologists Meeting
Colon cancer: Colon cancer perspective and analysis in Turkey. Fact and figures public health:
Screennig and prevention, colon cancer and nutrition
Seda Kansu
Pembe Hanım, Turkey
T
he large differences in cancer rates among countries, striking changes in these rates among migrating populations, and
rapid changes over time within countries indicate that some aspect of lifestyle or environment is largely responsible for
the common cancersThe incidence rates of colon cancer are high in North America and northern Europe, lower in southern
Europe, and much lower in Asia and Africa. It is widely believed that environmental factors, particularly dietary patterns,
account for most of this marked variation in rates. By and large, the number one cancer that one can prevent through diet
is colorectal cancer. Studies and researches have revealed that a healthy balanced diet that includes a variety of fruits and
vegetables, whole grains, lean protein, lower fat milk products and healthy fats has been linked to a decreased risk of colorectal
cancer. Conversely, a diet high in fat and calories, low in fibre, vegetables and fruits and eating too much red meat and processed
meats,has been linked to an increased risk of the disease. There is a great variance worldwide in the incidence of colorectal
cancer with some countries having 10 to 20 times the rate of other countries. Although genetics may play a role in the disease,
many researchers believe that as much as 90% of these differences can be explained by dietary factors alone. Fortunately, there
are many dietary habits and nutrients that may help to prevent this devastating and potentially deadly disease. Key nutrition
facts for colon cancer is considered to be a great challenge for the prevention of colon cancer. Diet: risk factors you can change,
nutrition /supplemention, oxidation and antioxidant rescue.
seda.kansu@pembehanim.com,
a.sedakansu@gmail.comFrom traditional knowledge to an innovative approach for application of lactic acid bacteria in
human and veterinary medicine
Svetoslav Dimitrov Todorov
Universidade Federal de Viçosa, Brazil
T
he modern human and veterinary medicines are based on application of different approaches in treatment of diseases
related to well establish therapeutically practices and new technologies. Complexity of treatment of pathogenic bacteria
includes not only application of antibiotics (and other antimicrobial preparations), buy the modern treatment takes care for
protecting and reestablishes the integrity of the natural GIT microbiota. By definition, bacteriocins, an antimicrobial peptides
produced by LAB are ribosomally synthesized antimicrobial proteins (polypeptide or small proteins), usually active against
genetically related species. In last decade, based on the intensive research in area of bacteriocins, we have sufficient examples
for bacteriocins that may have application in controlling Gram-negative bacteria, some yeast,
Mycobacterium
spp. and even
viruses. Bacteriocins have been of interest by medical industry, based on simple fact that they are produced by non-pathogenic
bacteria, most of the with GRAS status, that normally are present the human gastro intestinal tract (GIT) and several fermented
food products. In the last decades, bacteriocins have also been suggested to be candidates in the cancer treatment; were tested
as potential AIDS drugs, but the studies did not progress beyond
in vitro
tests on cell lines; some bacteriocins been suggested
as a potential for treatment of other viral infections as single or accompanying therapy; bacteriocins been suggested a possible
potential medical and veterinary application for treatment of mastitis; been suggested as accompanying therapy against MRSA
or bacterial vaginosis.
slavi310570@abv.bgJ Gastrointest Dig Syst 2016, 6:4(Suppl)
http://dx.doi.org/10.4172/2161-069X.C1.035